Diagnostic Histopathology
Volume 14, Issue 5 , Pages 236-246 , May 2008

Thyroid epithelial tumours

References 

  1. De Lellis RA, Williams ED. Tumours of the thyroid and parathyroid. In:  De Lellis RA,  Lloyd RV,  Heitz PV,  Eng C editor. World Health Organization Classification of Tumours Pathology & Genetics. Tumours of Endocrine Organs. Oxford: Oxford University Press; 2004;p. 50–105
  2. Rosai J, Carcangiu ML, De Lellis RA. Atlas of tumor pathology. Tumors of the thyroid gland. 3rd edn.. Washington DC: AFIP; 1992;19–258
  3. Baloch ZW, Livolsi VA. Pathology of the thyroid gland. In:  Livolsi VA,  Asa SL editor. Endocrine Pathology. Edinburgh: Churchill Livingstone; 2002;p. 61–101
  4. Hazard JB, Kenion R. Atypical adenoma of the thyroid. Arch Pathol Lab Med. 1954;58:554–563
  5. Cheung CC, Boerner SL, MacMillan CM, Ramyar L, Asa SL. Hyalinizing trabecular tumor of the thyroid: a variant of papillary carcinoma proved by molecular genetics. Am J Surg Pathol. 2000;24:1622–1626
  6. Papotti M, Volante M, Giuliano A, et al. RET/PTC Activation in hyalinizing trabecular tumors of the thyroid. Am J Surg Pathol. 2000;24:1615–1621
  7. In:  Livolsi VA editors. Surgical Pathology of the Thyroid. Edinburgh: WB Saunders; 1990;p. 131–274
  8. Chan JKC. Tumors of the thyroid and parathyroid glands. In:  Fletcher CDM editors. Diagnostic Histopathology of Tumors. Edinburgh: Churchill Livingstone; 2001;p. 959–1038
  9. Harach HR, Franssila KO, Wasenius VM. Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systemic autopsy study. Cancer. 1985;56:531–538
  10. Bisi H, Fernandes VS, de Carvalho RY, Koch L, Abdo AH, de Brito T. The prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to incidental carcinoma. Cancer. 1989;64:1888–1893
  11. Fink A, Tomlinson G, Freeman JL, Rosen IB, Asa SL. Occult micropapillary carcinoma associated with benign disease and unrelated thyroid neoplasms. Mod Pathol. 1996;9:816–820
  12. Rosai J, Livolsi VA, Sobrinho-Simões M, Williams ED. Renaming papillary microcarcinomas of the thyroid gland: the Porto proposal. Int J Surg Pathol. 2003;11:249–251
  13. Matos PS, Ferreira APC, Ward LS. Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series. Endocr Pathol. 2006;17:165–173
  14. Piersanti M, Ezzat S, Asa SL. Controversies in papillary microcarcinoma of the thyroid. Endocr Pathol. 2003;14:183–191
  15. Lindsay S. Carcinoma of the Thyroid Gland: A Clinical and Pathologic Study of 293 Patients at the University of California Hospital. Springfield: Chares C Thomas; 1960;
  16. Chen TKK, Rosai J. Follicular variant of thyroid papillary carcinoma: a clinicopathologic study of six cases. Am J Surg Pathol. 1977;1:123–130
  17. Matos PS, Ferreira AP, Facuri FO, Assumpção LVM, Ward LS. Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy. Histopathol. 2005;47:391–401
  18. Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL. Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol. 2001;14:338–342
  19. Beesley MF, McLaren KM. Cytokeratin 19 and Galectin-3. Immunohistochemistry in the differential diagnosis of solitary thyroid nodules. Histopathol. 2002;41:236–243
  20. Hawk WA, Hazard JB. The many appearances of papillary carcinoma of the thyroid. Cleve Clin Q. 1976;43:207–216
  21. Ostrowski ML, Merino MJ. Tall cell variant of papillary thyroid carcinoma. A reassessment and immunohistochemical study with comparison to the usual type of papillary carcinoma of the thyroid. Am J Surg Pathol. 1996;20:964–974
  22. Rüter A, Dreifus J, Jones M, et al. Overexpression of p53 in tall cell variants of papillary thyroid carcinoma. Surgery. 1996;120:1046–1050
  23. Evans HL. Collumnar cell carcinoma of the thyroid: a report of two cases of an aggressive variant of thyroid carcinoma. Am J Pathol. 1986;85:77–80
  24. Sobrinho-Simões M, Nesland JM, Johannessen JV. Columnar cell carcinoma: Another variant of poorly differentiated carcinoma of the thyroid. Am J Clin Pathol. 1988;89:264–267
  25. Wenig BM, Thompson LD, Adair CF, Shmookler B, Heffess CS. Thyroid papillary carcinoma of columnar cell type. A clinicopathologic study of 16 cases. Cancer. 1998;82:740–753
  26. Matos PS. Tumores do Sistema Endócrino: Glândula Tireóide. In: Billis A, Vassallo J eds. Patologia Diagnóstica de Tumores. Impressão Digital do Brasil Gráfica e Editora Ltda. IDB/2004; 1–24.
  27. Carcangiu ML, Bianchi S. Diffuse sclerosing variant of papillary carcinoma of the thyroid. A histologic and immunohistochemical study of 15 cases. Am J Surg Pathol. 1989;3:1041–1049
  28. Soares J, Limbert E, Sobrinho-Simões M. Diffuse sclerosing variant of papillary carcinoma. A clinicopathologic study of 10 cases. Pathol Res Pract. 1989;185:200–206
  29. Gomez-Morales M, Alvaro T, Munoz M, et al. Diffuse sclerosing papillary carcinoma of the thyroid gland. Immunohistochemical analysis of the host immune response. Histopathology. 1991;18:427–433
  30. Sobrinho-Simões M, et al. Diffuse follicular variant of papillary carcinoma of the thyroid: report of eight cases of a distinct agressive type of thyroid tumor. Surg Pathol. 1990;3:189–203
  31. Mizukami Y, Nonomura A, Michigishi T, Ohmura K, Nogushi M, Ishizaki T. Diffuse follicular variant of papillary carcinoma of the thyroid. Histopathology. 1995;27:575–577
  32. Apel RL, Asa SL, Livolsi VA. Papillary Hurthle cell carcinoma with lymphocytic stroma. Am J Surg Pathol. 1995;19:810–814
  33. Nikiforov YE, Erickson LA, Nikiforova MN, Caudill CM, Lloyd RV. Solid variant of papillary thyroid carcinoma: incidence, clinical-pathologic characteristics, molecular analysis, and biologic behavior. Am J Surg Pathol. 2001;5:1478–1484
  34. Carcangiu ML, Zampi G, Rosai J. Poorly differentiated (insular) thyroid carcinoma. A reinterpretation of Langhans ‘‘Wuchernde Struma”. Am J Surg Pathol. 1984;8:655–668
  35. Carcangiu ML, Steeper T, Zampi G, Rosai J. Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol. 1985;83:135–158
  36. Vickery AL, Carcangiu ML, Johannessen JV, Sobrinho-Simões M. Papillary carcinoma. Sem Diagn Pathol. 1985;2:90–100
  37. Haigh PI, Ituarte RH, Wu HS, et al. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer. 2001;91:2335–2342
  38. Albores-Saavedra J, Housini I, Vuitch F, Snyder WH. Macroffolicular variant of papillary thyroid carcinoma with minor insular component. Cancer. 1997;80:1110–1116
  39. Lang W, Georgii A, Stauch G, Kienzle E. The differentiation of atypical adenomas and encapsulated follicular carcinoma in the thyroid. Virchow Arch A (Pathol Anat Histol). 1980;385:125–141
  40. Franssila KO, Ackerman LV, Brown CL, Hedinger CE. Follicular carcinoma. Semin Diagn Pathol. 1985;2:101–122
  41. Lang W, Choritz H, Hundeshagen H. Risk factors in follicular thyroid carcinomas. A retrospective follow up covering a 14-year period with emphasis on morphological findings. Am J Surg Pathol. 1986;10:246–255
  42. Langhans T. Über die epithelialen formen der malignen struma. Virchows Arch Pathol Anat. 1907;189:69
  43. Nishida T, Katayama S, Tsujimoto M, Nakamura J, Matsuda H. Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol. 1999;23:205–211
  44. Giuffrida D, Gharib H. Cardiac metastasis from primary anaplastic thyroid carcinoma: report of three cases and review of the literature. Endocr Relat Cancer. 2001;8:71–73
  45. Papotti M, Negro F, Carney JA, Bussolati G, Lloyd RV. Mixed medullary-follicular carcinoma of the thyroid. A morphological, immunohistochemical and in situ hybridization analysis of 11 cases. Virchows Arch. 1997;430:397–405
  46. Fusco , et al. A new oncogene in human thyroid papillary carcinomas and their lymph node metastasis. Nature. 1987;328:170
  47. Zhu Z, Gandhi M, Nikiforowa MN, Fischer AH, Nikiforov YE. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Am J Clin Pathol. 2003;120:71–77
  48. Nikiforova MN, Biddinger PW, Caudill CM, Kroll TG, Nikiforov YE. PAX 8-PPAR γ Rearrangement in thyroid tumors. RT-PCR and immunohistochemical analyses. Am J Surg Pathol. 2002;26:1016–1023
  49. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA. High prevalence of BRAF mutations in thyroid câncer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res. 2003;63:1454–1457
  50. Xu X, Quiros RM, Gattuso P, Aun KB, Prinz RA. High prevalence of BRAF gene mutation in papillary thyroid carcinoma and thyroid tumor cell lines. Cancer Res. 2003;63:4561–4567
  51. Kebebew E, Clark OH. Medullary thyroid Câncer. In:  Clark OH,  Duh Q-Y,  Perrier ND,  Jahan T editor. Endocrine Tumours. Atlas of clinical oncology. Chicago: BC Decker; 2003;p. 37–48
  52. Soares P, Cameselle- Teijeiro J, Sobrinho-Simões M. Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid. Histopathology. 2004;24:205–210

PII: S1756-2317(08)00050-9

doi: 10.1016/j.mpdhp.2008.03.005

Diagnostic Histopathology
Volume 14, Issue 5 , Pages 236-246 , May 2008

Article Tools

* Image Usage & Resolution